This study examines the role of target venture CEO overconfidence in the acquisitions initiated by established firms. We postulate that the more confident a target venture CEO, the greater the difficulty for an acquirer to negotiate and integrate with the target, reducing the likelihood of a complet...
In vitro secondary pharmacology assays are an important tool for predicting clinical adverse drug reactions (ADRs) of investigational drugs. We created the Secondary Pharmacology Database (SPD) by testing 1958 drugs using 200 assays to validate target-AD
The inclusion of industry and year dummies ensures that the model accounts for potential variations across different sectors and temporal changes, thereby enhancing the robustness and generalizability of the findings. The high F-statistic value of 530.47, significant at the 1% level, confirms the overa...
Over 500 variables (including counting dummies for categorical ones) are considered initially. The database to estimate the incident type models has one observation per vessel per year whereas the database to estimate the detention model has multiple observations per vessel per year since vessels can...